FDA Requests Updates to Testosterone Therapy Labels
Medical Xpress1 min read26 words
The U. S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect newer clinical evidence.
Read the original at Medical Xpress
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.